![]() |
|
|
Vol. 297, Issue 1, 240-246, April 2001
National Research Institute of Chinese Medicine, Taipei, Taiwan,
Republic of China
In vivo and in vitro studies were carried out to examine the putative
hypotensive actions of S-petasin, a sesquiterpene
extracted from the medicinal plant Petasites formosanus.
Intravenous S-petasin (0.1-1.5 mg/kg) in anesthetized
rats produced a dose-dependent hypotensive effect. In isolated aortic
ring, isometric contraction elicited by KCl or the L-type
Ca2+ channel agonist Bay K 8644 was reduced by
S-petasin (0.1-100 µM), an action not affected by the
cyclooxygenase inhibitor indomethacin, nitric-oxide synthase inhibitor
N
-nitro-L-arginine, guanylyl
cyclase inhibitor methylene blue, or removal of vascular
endothelium. Pretreatment with S-petasin for 10 min shifted the concentration-response curve for KCl (15-90 mM)-induced contraction to the right and reduced the maximal response. In Ca2+-depleted and high K+-depolarized aortic
rings preincubation with S-petasin attenuated the
Ca2+-induced contraction in a concentration-dependent
manner, suggesting that S-petasin reduced
Ca2+ influx into vascular smooth muscle cells (VSMCs).
Moreover, in cultured VSMCs, whole-cell patch-clamp recording indicated
that S-petasin (1-50 µM) inhibited the L-type
voltage-dependent Ca2+ channel (VDCC) activities.
Intracellular Ca2+ concentration
([Ca2+]i) estimation using the fluorescent
probe
1-[2-(5-carboxyoxazol-2-yl)-6-aminobenzofuran-5-oxy]-2-(2'-amino-5'-methylphenoxy)-ethane-N,N,N,N-tetraacetic acid pentaacetoxymethyl ester indicated that S-petasin
(10, 100 µM) suppressed the KCl-stimulated increase in
[Ca2+]i. Taken together, the results
suggested that a direct Ca2+ antagonism of L-type VDCC in
vascular smooth muscle may account, at least in part, for the
hypotensive action of S-petasin.
This article has been cited by other articles:
![]() |
R. B. Lipton, H. Gobel, K. M. Einhaupl, K. Wilks, and A. Mauskop Petasites hybridus root (butterbur) is an effective preventive treatment for migraine Neurology, December 28, 2004; 63(12): 2240 - 2244. [Abstract] [Full Text] [PDF] |
||||